These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3802580)

  • 21. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rate of development and the size of the necrotic focus in patients with myocardial infarct treated by intracoronary thrombolysis].
    Golikov AP; Zingerman LS; Polumiskov VIu; Berestov AA; Avilova OA
    Kardiologiia; 1986 May; 26(5):12-7. PubMed ID: 3735912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase.
    Vandeplassche G; Hermans C; Somers Y; Van de Werf F; de Clerck F
    J Am Coll Cardiol; 1993 Apr; 21(5):1269-79. PubMed ID: 8459087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction.
    Schwerdt H; Ozbek C; Fröhlig G; Schieffer H; Bette L
    Cardiovasc Res; 1990 Apr; 24(4):328-34. PubMed ID: 2189569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic short-term fibrinolysis with high-dose streptokinase in acute myocardial infarction: time course of biochemical parameters.
    Golf SW; Temme H; Kempf KD; Bleyl H; Brüstle A; Bödeker R; Heinrich D
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):723-9. PubMed ID: 6396365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction.
    Hackworthy RA; Sorensen SG; Fitzpatrick PG; Barry WH; Menlove RL; Rothbard RL; Anderson JL
    Am Heart J; 1988 Oct; 116(4):903-14. PubMed ID: 3051985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous streptokinase in evolving acute myocardial infarction.
    Ganz W; Geft I; Shah PK; Lew AS; Rodriguez L; Weiss T; Maddahi J; Berman DS; Charuzi Y; Swan HJ
    Am J Cardiol; 1984 May; 53(9):1209-16. PubMed ID: 6711421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of early reperfusion on use of triphenyltetrazolium chloride to differentiate viable from non-viable myocardium in area of risk.
    Freeman I; Grunwald AM; Robin B; Rao PS; Bodenheimer MM
    Cardiovasc Res; 1990 Feb; 24(2):109-14. PubMed ID: 1691681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of serum cardiac enzymes after intracoronary thrombolytic therapy. Creatine kinase, creatine kinase MB isozyme, lactate dehydrogenase, and serum glutamic-oxaloacetic transaminase.
    Wei JY; Markis JE; Malagold M; Grossman W
    Arch Intern Med; 1985 Sep; 145(9):1596-600. PubMed ID: 4026489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced infarct size in nonreperfused myocardial infarction by combined infusion of isosorbide dinitrate and streptokinase.
    Hildebrandt P; Torp-Pedersen C; Joen T; Iversen E; Jensen G; Jeppesen D; Melchior T; Schytten HJ; Ringsdal V; Jensen J
    Am Heart J; 1992 Nov; 124(5):1139-44. PubMed ID: 1442478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of early coronary patency on the evolution of myocardial infarction: a prospective arteriographic study.
    Timmis AD; Griffin B; Crick JC; Nelson DJ; Sowton E
    Br Heart J; 1987 Oct; 58(4):345-51. PubMed ID: 3314951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction.
    van der Laarse A; Vermeer F; Hermens WT; Willems GM; de Neef K; Simoons ML; Serruys PW; Res J; Verheugt FW; Krauss XH
    Am Heart J; 1986 Oct; 112(4):672-81. PubMed ID: 3532742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
    Rao Y; Wang YL; Zhang WS; Liu J
    Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arrhythmias with brief, high-dose intravenous streptokinase infusion in acute myocardial infarction.
    Cercek B; Horvat M
    Eur Heart J; 1985 Feb; 6(2):109-13. PubMed ID: 4006964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
    French CJ; Zaman AK; Sobel BE
    Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy.
    Waller BF; Rothbaum DA; Pinkerton CA; Cowley MJ; Linnemeier TJ; Orr C; Irons M; Helmuth RA; Wills ER; Aust C
    J Am Coll Cardiol; 1987 Apr; 9(4):785-801. PubMed ID: 2951422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracoronary thrombolysis in acute myocardial infarction: experimental background and clinical experience.
    Ganz W; Ninomiya K; Hashida J; Fishbein MC; Buchbinder N; Marcus H; Mondkar A; Maddahi J; Shah PK; Berman D; Charuzi Y; Geft I; Shell W; Swan HJ
    Am Heart J; 1981 Dec; 102(6 Pt 2):1145-9. PubMed ID: 7315719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction.
    de Zwaan C; Willems GM; Vermeer F; Res J; Verheugt FW; van der Laarse A; Simoons ML; Lubsen J; Hermens WT
    Br Heart J; 1988 Feb; 59(2):175-83. PubMed ID: 3342158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species.
    Goto M; Miura T; Iliodoromitis EK; O'Leary EL; Ishimoto R; Yellon DM; Iimura O
    Cardiovasc Res; 1991 Nov; 25(11):943-9. PubMed ID: 1813123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.